Cac Holdings Corporation · TSE:4725
Cac — Q3 FY2024 Earnings Presentation
22 slides from Cac's earnings presentation, Nov 12, 2024
Slide 1: Consolidated Financial Results for the 3rd quarter FY2024
Consolidated Financial Results for the ３ｒｄ quarter FY2024 － January to September 2024－
Slide 2: Agenda
Agenda 1. Overview of Financial Results for the 3 rd quarter FY2024 2. Consolidated Forecasts for FY2024 3. Progress of Medium-Term Management Plan 4. Reference
Slide 3: Overview of Financial Results for the 3rd quarter FY2024
1 Overview of Financial Results for the ３ｒｄ quarter FY2024
Slide 4: Overview of Consolidated Results
Overview of Consolidated Results YoY change 3rd quarter 3rd quarter FY2023 FY2024 (JPY mil) Amount % ▍Overview of profit and loss Net sales 37,555 39,145 +1,590 +4.2% Net sales increased mainly due to the growth of core subsidiaries, the Gross profit 9,035 10,059 +1,023 +11.3% contribution of newl
Slide 5: Net Sales Analysis
Net Sales Analysis Domestic IT increased year-on-year mainly owing to the growth of core subsidiaries and the inclusion of newly consolidated subsidiaries, although there was an impact from the exclusion of consolidated subsidiaries. Overseas IT decreased from the same period of the previous yea
Slide 6: Adjusted EBITDA Analysis
Adjusted EBITDA Analysis In addition to active investments to create a foundation for growth (such as new business development and investment in human capital), the exclusion of consolidated subsidiaries had a negative impact. However, adjusted EBITDA increased by ¥360 million year-on-year due to
Slide 7: Net Sales / Adjusted EBITDA by Segment
Net Sales / Adjusted EBITDA by Segment ▍Net Sales For details, please refer to Overview by Segment. 3rd quarter FY2023 3rd quarter FY2024 YoY change (JPY mil) Amount % Amount % Amount % Domestic IT 26,635 70.9% 28,977 74.0% +2,341 +8.8% Overseas IT 10,919 29.1% 10,168 26.0% -751 - 6.9% Total 37,555
Slide 8: (Reference) Net Sales / Operating Profit by Segment
(Reference) Net Sales / Operating Profit by Segment ▍Net sales 3rd quarter FY2023 3rd quarter FY2024 YoY change (JPY mil) Amount % Amount % Amount % Domestic IT 26,635 70.9% 28,977 74.0% +2,341 +8.8% Overseas IT 10,919 29.1% 10,168 26.0% -751 - 6.9% Total 37,555 100.0% 39,145 100.0% +1,590 +4.2% ▍Op
Slide 9: Orders Received / Order Backlog by Segment
Orders Received / Order Backlog by Segment ▍Orders Received For details, please refer to Overview by Segment. 3rd quarter FY2023 3rd quarter FY2024 YoY change (JPY mil) Amount % Amount % Amount % Domestic IT 29,278 68.3% 28,139 73.7% -1,139 - 3.9% Overseas IT 13,564 31.7% 10,030 26.3% -3,533 - 26.1%
Slide 10: Overview by Segment: Domestic IT
Overview by Segment: Domestic IT 3rd quarter 3rd quarter YoY change (JPY mil) FY2023 FY2024 ▍Summary 28,139 Orders 29,278 -1,139 - 3.9% Orders received and Order backlog received decreased due to a decrease in orders for pharmaceutical companies and service companies. Net sales 26,635 28,977 +2,34
Slide 11: Overview by Segment: Overseas IT
Overview by Segment: Overseas IT 3rd quarter 3rd quarter (JPY mil) YoY change FY2023 FY2024 ▍Summary 10,030 Orders 13,564 -3,533 -26.1% received Orders received, Net sales and Order backlog decreased due to a rebound decline from a large-scale financial project in India reported in the Net sales 1
Slide 12: Forecasts for FY2024
２ Forecasts for FY2024
Slide 13: Forecasts for FY2024
Forecasts for FY2024 As the progress has been largely in line with expectations, the full-year earnings forecast remains unchanged. The annual dividend forecast remains unchanged. FY2024 FY2023 3rd quarter (JPY mil) Forecast % Results Results Net sales 39,145 51,500 +76.0% 50,539 Adjusted EBITDA
Slide 14: Progress of Medium-Term Management Plan
３ Progress of Medium-Term Management Plan
Slide 15: Trend in Net Sales of P&S (Products and Services)
Trend in Net Sales of P&S (Products and Services) In the product and service business, sales remained strong. (JPY 100 mil) 60 FY2025 Targets 50 17 21 15 21 Q4 17 1２ Q3 19 Q2 10 Q1 FY2022 FY2023 3Q2024 15 Copyright © CAC Holdings Corporation All Rights Reserved.
Slide 16: Status of Investments for Growth
Status of Investments for Growth From FY2022 through the third quarter of 2024, we spent about 7.2 billion yen. Investments were made with assets held and borrowings. Main Investment Investment Investment execution Investment fund investment execution amount execution amount (Until 3rd quarter a
Slide 17: Reference
4 Reference
Slide 18: Orders Received by Industry
Orders Received by Industry 3rd quarter FY2023 3rd quarter FY2024 YoY change (JPY mil) Amount % Amount % Amount % Financial services 16,431 38.4% 13,332 34.9% -3,099 - 18.9% Pharmaceuticals 7,723 18.0% 6,388 16.7% -1,334 - 17.3% Manufacturing 5,758 13.4% 5,937 15.6% +178 +3.1% 4,847 12.7% Informatio
Slide 19: Net Sales by Industry
Net Sales by Industry 3rd quarter FY2023 3rd quarter FY2024 YoY change (JPY mil) Amount % Amount % Amount % Financial services 13,455 35.8% 13,354 34.1% -100 - 0.7% Pharmaceuticals 6,178 16.5% 6,572 16.8% +393 +6.4% Manufacturing 5,229 13.9% 5,922 15.1% +693 +13.3% 5,573 14.2% Information & communic
Slide 20: Orders Received by Segment & Industry
Orders Received by Segment & Industry 3rd quarter FY2023 3rd quarter FY2024 YoY change (JPY mil) Amount % Amount % Amount % Domestic IT 29,278 68.3% 28,139 73.8% -1,139 -3.9% Financial services 8,941 20.9% 9,033 23.7% +91 +1.0% Pharmaceuticals 7,133 16.7% 5,800 15.2% -1,332 -18.7% Manufacturing 4,45
Slide 21: Net Sales by Segment & Industry
Net Sales by Segment & Industry 3rd quarter FY2023 3rd quarter FY2024 YoY change (JPY mil) Amount % Amount % Amount % Domestic IT 26,635 70.9% 28,977 74.0% +2,341 +8.8% Financial services 8,488 22.6% 9,570 24.4% +1,082 +12.8% Pharmaceuticals 5,706 15.3% 5,899 15.1% +192 +3.4% Manufacturing 4,064 10.
Slide 22: Contact
Contact Financial Strategy Dept. Tel: ＋81-3-6667-8070 E-mail: prir@cac.co.jp https://www.cac-holdings.com/eng/